We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
German restructure of Merck.
- Abstract
The article reports that Merck KGaA, a company which markets approximately 60 ethical drugs for the treatment of cancer, cardiovascular diseases and diabetes, has restructured its Pharmaceuticals business in Germany. The business with ethicals, which formerly operated as Merck Pharma Germany as a part of Merck KGaA, has been transferred into a legally self-standing company as of 1st November 2004. The new Merck Pharma GmbH in Darmstadt, a wholly owned affuliate of Merck KGaA, is one of the largest subsidiaries of ethicals within the Merck group.
- Subjects
GERMANY; MERGERS &; acquisitions; MERCK KGaA; PHARMACEUTICAL industry; CORPORATE reorganizations; CORPORATE growth
- Publication
LC-GC Europe, 2004, Vol 17, Issue 12, p623
- ISSN
1471-6577
- Publication type
Article